Cancer cell line from thyroid of a Poorly Differentiated Thyroid Carcinoma donor.


Cancer cell line from a Rare thyroid carcinoma donor's pleural effusion.


Rare thyroid carcinoma Cancer cell line derived from thyroid.


Cancer cell line from a Epidermoid Cell Carcinoma of Lung patient's brain.


Cancer cell line derived from a Epidermoid Cell Lung Carcinoma patient's pulmo.


Cancer cell line from entire skin of a donor with LUSC.


Cancer cell line derived from lymph node of a Squamous cell lung carcinoma donor.


Epidermoid Cell Lung Carcinoma Cancer cell line from pleural effusion.


Cancer cell line derived from right lower lobe of lung of a patient with Squamous Cell Lung Carcinoma.


Cancer cell line derived from a PEL patient's portion of blood.


Cancer cell line derived from a primary effusion lymphoma donor's ascitic fluid.


Cancer cell line from a Primary effusion lymphoma patient's pleural effusion.


Cancer cell line from a Primary effusion lymphoma patient's portion of blood.


Primary effusion lymphoma Cancer cell line from ascitic fluid.


Cancer cell line from pleural effusion of a Primary effusion lymphoma donor.


AIDS-Associated Immunoblastic Large Cell Lymphoma Cancer cell line derived from pleural effusion.


Transformed cell line derived from portion of blood of a Waldenstrom macroglobulinemia patient.


Cancer cell line from medulla ossium of a Waldenstrom Macroglobulinemia donor.


Transformed cell line derived from portion of blood of a Waldenström macroglobulinemia donor.


Cancer cell line from a Waldenström macroglobulinemia patient's medulla ossium.


Transformed cell line from a Fanconi Anemia, Complementation Group C donor's skin organ.


Finite cell line derived from entire skin of a Fanconi Anemia, Complementation Group C donor.


Transformed cell line derived from a Fanconi Anemia, Complementation Group C donor's vertebrate blood.


Fanconi anemia Finite cell line from skin organ.


Transformed cell line derived from skin organ of a Fanconi anemia patient.


Transformed cell line from a Fanconi anemia donor's vertebrate blood.


Finite cell line from a Fanconi anemia donor's skin of arm.


Fanconi anemia Finite cell line derived from zone of skin of anterior part of thorax.


Fanconi anemia Transformed cell line derived from zone of skin of anterior thoracic region.


Finite cell line from forearm skin of a patient with Fanconi anemia.


Cancer cell line from portion of blood of a Acute Myelocytic Leukemia donor.


Cancer cell line derived from a Non-Small Cell Cancer of the Lung donor's pulmo.


Cancer cell line derived from lymph node of a Non-Small Cell Carcinoma of Lung patient.


Cancer cell line from pleural effusion of a patient with Non-Small Cell Carcinoma of Lung.


Cancer cell line derived from nodus lymphaticus supraclavicularis axillae of a non-small cell lung cancer patient.


Telomerase immortalized cell line from cerebral falx of a donor with Meningothelial Meningioma.


Meningioma Cancer cell line from brain.


Cancer cell line from a Meningioma patient's lobi frontales.


Telomerase immortalized cell line derived from cerebral falx of a Meningioma patient.


Cancer cell line from a Meningioma patient's optic foramen.


Finite cell line from meninges of a donor with Meningioma.


Cancer cell line derived from brain rudiment of a patient with Gestational Choriocarcinoma.


Gestational Choriocarcinoma Cancer cell line from uterus.


Cancer cell line derived from a Gestational choriocarcinoma donor's presumptive brain.


Cancer cell line derived from uterus of a donor with Gestational choriocarcinoma.


Cancer cell line from pelvis of ureter of a patient with Renal Pelvis Urothelial Cancer.


Adenocarcinoma of Ovary Cancer cell line from gonad of genitalia of female organism.


Cancer cell line derived from a Adenocarcinoma of Ovary donor's ascitic fluid.


Cancer cell line derived from a Adenocarcinoma of ovary patient's gonada of genitalia of female organism.


Cancer cell line from a Adenocarcinoma of ovary donor's ascitic fluid.


Alveolar Ridge Squamous Cell Carcinoma Cancer cell line derived from alveolar bone.


Cancer cell line from lymph node of a Squamous cell carcinoma of the oral cavity donor.


Cancer cell line from a Squamous cell carcinoma of the oral cavity donor's pleural effusion.


Cancer cell line from a Squamous cell carcinoma of the oral cavity donor's lymph node of neck.


Cancer cell line from gum of a Squamous cell carcinoma of the oral cavity patient.


Cancer cell line from a Squamous cell carcinoma of the oral cavity donor's alveolar bone.


Cancer cell line from buccal mucosa of a patient with Squamous cell carcinoma of the oral cavity.


Cancer cell line from space of thoracic compartment of a Squamous cell carcinoma of the oral cavity patient.


Squamous cell carcinoma of the oral cavity Cancer cell line derived from regio oralis.


Cancer cell line derived from floor of oval cavity of a patient with Squamous cell carcinoma of the oral cavity.


Squamous cell carcinoma of the oral cavity Cancer cell line from Rivinus' gland.


Cancer cell line derived from a Squamous cell carcinoma of the oral cavity donor's retromolar triangle.


Cancer cell line from cavity of mouth of a Squamous cell carcinoma of the oral cavity donor.


Cancer cell line from tonsillar sinus of a Squamous cell carcinoma of the oral cavity donor.


Finite cell line from a Ehlers-Danlos syndrome patient's entire skin.


Ehlers-Danlos Syndrome Transformed cell line from vertebrate blood.


Ehlers-Danlos syndrome Finite cell line derived from skin organ.


Ehlers-Danlos syndrome Transformed cell line from portion of blood.


Cancer cell line from lymph node of neck of a Squamous Cell Carcinoma of the Buccal Mucosa patient.


Cancer cell line derived from a SCC of Buccal Mucosa patient's buccal mucosa.


Cancer cell line derived from lymph node of a donor with Tongue SCC.


Squamous Cell Carcinoma of Tongue Cancer cell line derived from lymph node of neck.


Cancer cell line derived from a Tongue SCC patient's tongue.


Tongue SCC Cancer cell line from anterior part of tongue.


Squamous cell carcinoma of the oral tongue Cancer cell line from lymph node.


Squamous cell carcinoma of the oral tongue Cancer cell line derived from lymph node of neck.


Cancer cell line from a Squamous cell carcinoma of the oral tongue patient's tongue.


Squamous cell carcinoma of the oral tongue Cancer cell line derived from anterior part of tongue.


Cancer cell line derived from a Ovarian Small Cell Carcinoma, Hypercalcemic Type patient's gonada of female organism reproductive system.


Cancer cell line derived from pelvis of a donor with Ovarian Small Cell Carcinoma, Hypercalcemic Type.


Cancer cell line derived from stratum granulosum of ovarian follicle of a patient with SCCOHT.


Small cell carcinoma of the ovary Cancer cell line from gonada of female reproductive system.


Small cell carcinoma of the ovary Cancer cell line derived from lesser pelvis.


Small cell carcinoma of the ovary Cancer cell line derived from granulosa cell layer of ovarian follicle.


Cancer cell line derived from a Burkitt's Lymphoma donor's portion of blood.


Cancer cell line derived from ascitic fluid of a donor with NHL, Burkitt lymphoma (BL).


Cancer cell line derived from lymph node of a Burkitt's lymphoma donor.


Burkitt Lymphoma Cancer cell line from pleural effusion.


Cancer cell line from medulla ossea of a Small Non-Cleaved Cell Lymphoma, Burkitt's Type donor.


Cancer cell line derived from lymph node of neck of a patient with Small Non-Cleaved Cell Lymphoma, Burkitt's Type.


Cancer cell line from inguen of a patient with NHL, Burkitt lymphoma (BL).


Burkitt lymphoma, unspecified site Cancer cell line from ileocaecal lymph node.


Finite cell line derived from entire skin of a patient with Ehlers-Danlos Syndrome, Type I.


Cancer cell line derived from a Pancreatic Serotonin Producing Neoplasm donor's lymph node.


Cancer cell line derived from lymph node of a patient with Serotonin-producing neuroendocrine tumor of pancreas.


Cancer cell line derived from a hairy cell leukemia donor's vertebrate blood.


Cancer cell line from a Hairy Cell Leukemia donor's spleen.


Cancer cell line from peritoneal fluid of a donor with Leukemic reticuloendotheliosis.


Classic hairy cell leukemia Cancer cell line derived from vertebrate blood.


Cancer cell line from spleen of a Classic hairy cell leukemia donor.


Cancer cell line derived from a Classic hairy cell leukemia patient's peritoneal fluid.


Transformed cell line derived from a benign prostatic hypertrophy donor's prostate.


Immunodeficiency by Defective Expression of MHC Class I Transformed cell line from skin organ.


Transformed cell line derived from entire skin of a Immunodeficiency by defective expression of MHC class I patient.


Cancer cell line from a Chronic Myeloid Leukemia, BCR::ABL1 Positive donor's portion of blood.


Chronic Granulocytic Leukemia Transformed cell line derived from vertebrate blood.


chronic granulocytic leukemia Cancer cell line from pleural effusion.


Cancer cell line from medulla ossium of a patient with Hematopoeitic - Chronic Myelocytic Leukemia (CML).


Cancer cell line derived from vertebrate blood of a patient with Chronic myeloid leukemia.


Transformed cell line from a Chronic myeloid leukemia patient's vertebrate blood.


Cancer cell line derived from pleural effusion of a Chronic myeloid leukemia patient.


Cancer cell line from medulla ossium of a Chronic myeloid leukemia donor.


Cancer cell line derived from a HPV-Independent Cervical Squamous Cell Carcinoma patient's uterine cervix.


Finite cell line from entire skin of a Cat-Cry Syndrome donor.


Transformed cell line derived from a Cri-du-Chat Syndrome patient's portion of blood.


Finite cell line from entire skin of a patient with Monosomy 5p syndrome.


Transformed cell line from vertebrate blood of a Monosomy 5p syndrome patient.


Cancer cell line from a Secondary Chondrosarcoma donor's upper end of tibia.


Cancer cell line from a Ollier Disease donor's proximal tibial epiphysis.


Finite cell line derived from entire skin of a donor with Porokeratosis.


Finite cell line from skin organ of a donor with Porokeratosis.


Gingival Squamous Cell Carcinoma Cancer cell line from gum.


Serous Surface Papillary Carcinoma of Ovary Cancer cell line from ascitic fluid.


Cancer cell line derived from a Mammary Carcinoma patient's mammary part of chest.


breast cancer Cancer cell line from entire skin.


Breast cancer, NOS Cancer cell line from ascitic fluid.


Cancer cell line derived from pleural effusion of a Breast Cancer patient.


Conditionally immortalized cell line derived from a Cancer of Breast donor's breast epithelium.


Cancer cell line derived from a breast cancer donor's axillary node.


Cancer cell line from tongue of a Tongue Adenosquamous Carcinoma patient.


Cancer cell line from a Squamous Cell Carcinoma of the Vulva donor's mammalian vulva.


Vulvar squamous cell carcinoma Cancer cell line from female pudendum.


Cancer cell line from a Dedifferentiated Chondrosarcoma patient's upper leg muscle.


Cancer cell line from inguinal lymph node of a Adenocarcinoma of Rectum patient.


Adenocarcinoma of the rectum Cancer cell line from terminal portion of intestine.


iCC Cancer cell line derived from ascitic fluid.


Cancer cell line from a Intrahepatic Cholangiocarcinoma patient's liver.


Cancer cell line from ascitic fluid of a Cholangiocarcinoma donor.


Cancer cell line from a Cholangiocarcinoma donor's liver.


Cancer cell line from a Cholangiocarcinoma patient's bile duct.


Cholangiocarcinoma Cancer cell line derived from extrahepatic bile duct.


Finite cell line from skin of breast of a Polycystic Kidney Disease donor.


Finite cell line derived from a Poikiloderma donor's skin organ.


Cancer cell line derived from a Thyroid Gland Anaplastic Carcinoma, Squamous Cell Carcinoma Pattern donor's thyroid.


Cancer cell line from a Follicular Thyroid Gland Carcinoma patient's pulmo.


Cancer cell line derived from a Thyroid Gland Follicular Cancer donor's thyroid.


Cancer cell line derived from a Well-differentiated Follicular Adenocarcinoma donor's lymph node of neck.


Cancer cell line derived from a Thyroid Gland Follicular Cancer donor's skull.


Cancer cell line from pulmo of a Differentiated thyroid carcinoma donor.


Cancer cell line from thyroid of a patient with Differentiated thyroid carcinoma.


Differentiated thyroid carcinoma Cancer cell line from lymph node of neck.


Cancer cell line derived from skull of a Differentiated thyroid carcinoma patient.


PTC Cancer cell line from thyroid.


Papillary Carcinoma of the Thyroid Cancer cell line from lymph node of neck.


Cancer cell line from a Bronchogenic Lung Carcinoma donor's hypoderm.


Cancer cell line from brain of a Neural Crest Tumor, Malignant donor.


Cancer cell line from a Neuroblastoma (Schwannian Stroma-Poor) donor's pulmo.


Cancer cell line from vertebrate blood of a neuroblastoma donor.


Cancer cell line from a NEUROBLASTOMA, MALIGNANT patient's lymph node.


Neural Crest Tumor, Malignant Cancer cell line from medulla ossium.


Cancer cell line derived from a Neuroblastoma donor's lymph node of neck.


Cancer cell line derived from a Neuroblastoma, NOS donor's spatium retroperitoneale.


Cancer cell line from a Neuroblastoma (NBL) donor's glandula suprarenalis.


Cancer cell line from abdominopelvis of a patient with Neuroblastoma, NOS.


Neuroblastoma Cancer cell line derived from brain.


Cancer cell line from pulmo of a Neuroblastoma patient.


Cancer cell line from a Neuroblastoma donor's portion of blood.


Cancer cell line from lymph node of a Neuroblastoma donor.


Cancer cell line from a Neuroblastoma patient's medulla ossium.


Cancer cell line derived from a Neuroblastoma patient's lymph node of neck.


Cancer cell line from a Neuroblastoma donor's spatium retroperitoneale.


Cancer cell line from a Neuroblastoma patient's glandula adrenalis.


Cancer cell line derived from a Neuroblastoma donor's axillary node.


Neuroblastoma Cancer cell line derived from abdominopelvic region.


Cancer cell line derived from Right pararenal lymph node. of a patient with Neuroblastoma.


Galactosemia Finite cell line from entire skin.


Transformed cell line from a Galactosemia patient's skin organ.


Galactosemia Transformed cell line derived from vertebrate blood.


Finite cell line from late embryo of a patient with Galactosemia.


Galactosemia Finite cell line derived from amniotic fluid.


Finite cell line from a Galactosemia patient's entire skin.


Transformed cell line derived from skin organ of a patient with Galactosemia.


Transformed cell line from a Galactosemia donor's portion of blood.


Galactosemia Finite cell line derived from late embryo.


Cancer cell line derived from a Neuroblastoma of Adrenal Gland patient's brain.


Cancer cell line derived from medulla ossium of a Adrenal Gland Neuroblastoma patient.


Cancer cell line derived from glandula suprarenalis of a donor with Adrenal Neuroblastoma.


Cancer cell line derived from a Adrenal Neuroblastoma patient's axillary node.


Cancer cell line derived from Right pararenal lymph node. of a donor with Neuroblastoma of Adrenal Gland.


Childhood Acute Megakaryocytic Leukemia (M7) Cancer cell line derived from portion of blood.


Cancer cell line from a Childhood Acute Megakaryoblastic Leukemia patient's medulla ossea.


Cancer cell line from a Pediatric Acute M7 Leukemia donor's bony orbit.


Cancer cell line from portion of blood of a Acute megakaryoblastic leukemia donor.


Cancer cell line derived from a Acute megakaryoblastic leukemia patient's medulla ossea.


Cancer cell line derived from eye socket of a Acute megakaryoblastic leukemia donor.


Cancer cell line from ascitic fluid of a donor with Non-Hodgkin's B-Cell Lymphoma.


Cancer cell line from a Non-Hodgkin's Lymphoma B-Cell patient's lymph node.


Cancer cell line derived from pleural effusion of a donor with Non-Hodgkin's B-Cell Lymphoma.


B-cell non-Hodgkin lymphoma Cancer cell line from ascitic fluid.


Cancer cell line from lymph node of a B-cell non-Hodgkin lymphoma patient.


Cancer cell line from a B-cell non-Hodgkin lymphoma patient's pleural effusion.


Finite cell line from a Argininosuccinate Synthetase Deficiency patient's pulmo.


Citrullinemia Type I Finite cell line from skin organ.


Transformed cell line derived from portion of blood of a patient with Citrullinemia Type I.


Finite cell line from a Citrullinemia type I patient's pulmo.


Citrullinemia type I Finite cell line derived from skin organ.


Citrullinemia type I Transformed cell line derived from portion of blood.


SCC of Mouth Cancer cell line derived from pleural effusion.


Cancer cell line derived from a SCC of Mouth patient's lymph node of neck.


Cancer cell line from a SCC of the Mouth patient's cavity of chest.


Squamous Cell Carcinoma of the Mouth Cancer cell line derived from regio oralis.


Finite cell line derived from a Lactic Acidosis patient's entire skin.


Finite cell line derived from a Fatal infantile lactic acidosis with methylmalonic aciduria donor's skin organ.


Cancer cell line from a Infiltrating Lobular Adenocarcinoma donor's ascitic fluid.


Infiltrating Lobular Carcinoma of Breast Cancer cell line derived from pleural effusion.


Cancer cell line from a Myeloid leukemia associated with Down Syndrome patient's portion of blood.


Cancer cell line from a Acute megakaryoblastic leukemia in children with Down syndrome patient's vertebrate blood.


Hereditary Non-Polyposis Colon Cancer (hMSH2, hMLH1, hPMS1, hPMS2) Cancer cell line derived from omentum.


Cancer cell line from a Hereditary Defective Mismatch Repair Syndrome patient's colon ascendens.


Cancer cell line from omentum of a patient with Lynch syndrome.


Cancer cell line from a Lynch syndrome donor's colon ascendens.


Cancer cell line derived from a Pancreatic Mucoepidermoid Carcinoma patient's liver.


Pancreatic Mucoepidermoid Carcinoma Cancer cell line from coeliac node.


Cancer cell line from liver of a Squamous cell carcinoma of pancreas patient.


Squamous cell carcinoma of pancreas Cancer cell line from celiac node.


Cancer cell line from a Squamous cell carcinoma of the esophagus patient's lymph node.


Cancer cell line derived from pleural effusion of a SCC of Esophagus patient.


Cancer cell line from oesophagus of a Squamous Cell Carcinoma of the Esophagus donor.


Cancer cell line from a Squamous cell car. - esophagus donor's inferior maxillary bone.


Cancer cell line derived from a Squamous cell carcinoma of the esophagus donor's lymph node.


Cancer cell line from pleural effusion of a Squamous cell carcinoma of the esophagus donor.


Cancer cell line derived from oesophagus of a donor with Squamous cell carcinoma of the esophagus.


Squamous cell carcinoma of the esophagus Cancer cell line derived from mammaliam mandible.


Finite cell line derived from skin organ of a donor with Ehlers-Danlos Syndrome, Type IV.


Transformed cell line derived from portion of blood of a Ehlers-Danlos Syndrome, Type IV donor.


Finite cell line derived from entire skin of a donor with Vascular Ehlers-Danlos syndrome.


Transformed cell line from portion of blood of a Vascular Ehlers-Danlos syndrome donor.


Cancer cell line from omentum of a Ovarian Mucinous Carcinoma donor.


Cancer cell line from a Mucinous Carcinoma of Ovary donor's gonad of reproductive system of female organism.


Mucinous adenocarcinoma of ovary Cancer cell line derived from omentum.


Mucinous adenocarcinoma of ovary Cancer cell line from female organism genitalia gonad.


Cancer cell line derived from ascitic fluid of a Mucinous adenocarcinoma of ovary patient.


Transformed cell line from vertebrate blood of a patient with Amyotrophic lateral sclerosis.


Induced pluripotent stem cell from a Lou Gehrig Disease donor's portion of blood.


Finite cell line derived from a Cockayne Syndrome Type B donor's entire skin.


Transformed cell line derived from a Cockayne Syndrome Type B patient's vertebrate blood.


Cockayne Syndrome Type B Finite cell line from skin of buttock.


Finite cell line derived from a Cockayne Syndrome patient's entire skin.


Transformed cell line derived from a Cockayne Syndrome donor's vertebrate blood.


Finite cell line from entire skin of a donor with FTDALS1.


Induced pluripotent stem cell derived from entire skin of a patient with FTDALS1.


Transformed cell line from a FTDALS1 patient's vertebrate blood.


Finite cell line from entire skin of a Severe Infantile Spinal Muscular Atrophy donor.


Induced pluripotent stem cell from a Severe Infantile Spinal Muscular Atrophy patient's skin organ.


Severe Infantile Spinal Muscular Atrophy Transformed cell line derived from portion of blood.


Infantile spinal muscular atrophy, type I [Werdnig-Hoffman] Induced pluripotent stem cell from lens crystallina.


Severe Infantile Spinal Muscular Atrophy Finite cell line derived from lens crystallina.


Finite cell line derived from entire skin of a Proximal spinal muscular atrophy type 1 donor.


Induced pluripotent stem cell from skin organ of a Proximal spinal muscular atrophy type 1 patient.


Proximal spinal muscular atrophy type 1 Transformed cell line derived from vertebrate blood.


Induced pluripotent stem cell derived from lens crystallina of a donor with Proximal spinal muscular atrophy type 1.


Proximal spinal muscular atrophy type 1 Finite cell line derived from lens.


Finite cell line derived from skin organ of a patient with HD.


Induced pluripotent stem cell from a Huntington's Chorea donor's skin organ.


Transformed cell line from vertebrate blood of a Huntington's Chorea patient.


Huntington's disease Finite cell line derived from late embryo.


Finite cell line from skin organ of a Huntington disease patient.


Huntington disease Induced pluripotent stem cell derived from skin organ.


Transformed cell line from portion of blood of a donor with Huntington disease.


Huntington disease Finite cell line from late embryo.


Cancer cell line from pleural effusion of a Childhood Precursor T-Lymphoblastic Lymphoma patient.


Cancer cell line from a T-cell non-Hodgkin lymphoma donor's pleural effusion.


gliosarcoma Cancer cell line derived from brain.


Cancer cell line from Brain, left fronto-parietal lobe. of a gliosarcoma patient.


Cancer cell line derived from a gliosarcoma patient's left parietal lobe.


Cancer cell line from temporoparietal junction of a Glioblastoma with a Sarcomatous Component patient.


Gliosarcoma Cancer cell line from brain.


Cancer cell line derived from a Gliosarcoma patient's Brain, left fronto-parietal lobe..


Cancer cell line derived from a Gliosarcoma donor's left parietal lobe.


Cancer cell line from a Gliosarcoma donor's temporoparietal junction.


Medulloblastoma, group 3 Cancer cell line derived from ascitic fluid.


Medulloblastoma, group 3 Cancer cell line derived from epencephalon-1.


Cancer cell line from brain of a donor with Medulloblastoma.


Cancer cell line derived from a Medulloblastoma patient's ascitic fluid.


Medulloblastoma Cancer cell line from epencephalon-1.


Medulloblastoma Cancer cell line from posterior cranial fossa.


Finite cell line derived from a Stiff Skin Syndrome donor's entire skin.


Stiff skin syndrome Finite cell line derived from skin organ.


Finite cell line from a Ehlers-Danlos Syndrome, Type V patient's skin organ.


X-linked Ehlers-Danlos syndrome Finite cell line from entire skin.


Cancer cell line derived from vertebrate blood of a Erythroleukemia donor.


Cancer cell line derived from medulla ossium of a patient with M6A.


Cancer cell line from a Acute erythroid leukemia donor's portion of blood.


Acute erythroid leukemia Cancer cell line from medulla ossea.


Cancer cell line derived from ascitic fluid of a patient with Adenocarcinoma of Pancreas.


Cancer cell line from lymph node of a donor with Adenocarcinoma of the pancreas.


Cancer cell line from a Adenocarcinoma of Pancreas donor's vertebrate hypodermis.


Cancer cell line derived from nodus lymphaticus supraclavicularis axillae of a patient with Pancreas Adenocarcinoma.


Adenocarcinoma of the pancreas Cancer cell line from pancreas.


Pancreas Adenocarcinoma Cancer cell line derived from liver.


Cancer cell line from posterior cranial fossa of a patient with Medulloblastoma, SHH-Activated, TP53-Mutant.


Cancer cell line from a Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type patient's portion of blood.


Cancer cell line derived from ascitic fluid of a patient with Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type.


Cancer cell line from a DLBCL Germinal Center B-Cell Type patient's lymph node.


Cancer cell line derived from pleural effusion of a patient with Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type.


Cancer cell line from a Diffuse Large B-Cell Lymphoma with a Germinal Center B-Cell Expression Profile donor's medulla ossea.


Cancer cell line from peritoneal fluid of a Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type patient.


Anaplastic Astrocytoma Cancer cell line derived from brain.


Cancer cell line derived from a High-grade astrocytoma, NOS donor's right temporal lobe.


Cancer cell line derived from Brain, occipito-medial region. of a donor with Grade III Astrocytic Tumor.


Cancer cell line from Brain, right occipital-parietal region. of a donor with Astrocytoma, anaplastic.


Cancer cell line from Brain, left temporo-medial region. of a Grade 3 Astrocytoma patient.


Cancer cell line from Brain, left temporo-occipital lobe. of a High Grade Astrocytoma donor.


Cancer cell line derived from left frontal lobe of a Grade III Astrocytoma donor.


Cancer cell line from brain of a donor with Anaplastic astrocytoma.


Cancer cell line derived from right temporal lobe of a donor with Anaplastic astrocytoma.


Cancer cell line derived from a Anaplastic astrocytoma donor's Brain, occipito-medial region..


Anaplastic astrocytoma Cancer cell line derived from Brain, right occipital-parietal region..


Cancer cell line derived from a Anaplastic astrocytoma donor's Brain, left temporo-medial region..


Cancer cell line derived from Brain, left temporo-occipital lobe. of a Anaplastic astrocytoma donor.


Anaplastic astrocytoma Cancer cell line derived from left frontal lobe.


Cancer cell line derived from a Anaplastic large cell lymphoma, ALK positive donor's vertebrate blood.


Anaplastic large cell lymphoma, ALK positive Cancer cell line derived from pleural effusion.


Cancer cell line from a Anaplastic Large Cell Lymphoma, ALK-Positive patient's CSF.


ALK-positive anaplastic large cell lymphoma Cancer cell line from vertebrate blood.


Cancer cell line derived from a ALK-positive anaplastic large cell lymphoma donor's pleural effusion.


ALK-positive anaplastic large cell lymphoma Cancer cell line from cerebral spinal fluid.


XXY Syndrome Finite cell line derived from skin organ.


Transformed cell line from portion of blood of a XXY Syndrome (Klinefelter Syndrome) donor.


47,XXY Syndrome Finite cell line from late embryo.


Finite cell line from amniotic fluid of a Klinefelter's Syndrome donor.


Cancer cell line from a Hepatosplenic T-cell lymphoma patient's vertebrate blood.


Hepatosplenic T-cell lymphoma Cancer cell line from portion of blood.


Cancer cell line from a Pharyngeal (including Hypopharyngeal and Oropharyngeal) squamous cell carcinoma donor's pleural effusion.


Cancer cell line derived from ascitic fluid of a patient with colorectal cancer.


Cancer cell line derived from a Cancer of the Large Intestine patient's spleen.


Finite cell line from a Gardner's Syndrome donor's entire skin.


Gardner Syndrome Cancer cell line derived from ascitic fluid.


Finite cell line derived from skin organ of a patient with Gardner syndrome.


Gardner syndrome Cancer cell line derived from ascitic fluid.


Cancer cell line from pulmo of a Thoracic SMARCA4-Deficient Undifferentiated Tumor patient.


Cancer cell line from a SMARCA4-UT donor's pleural effusion.


Cancer cell line from tongue of a donor with OED.


Cervical Cancer (all types) Cancer cell line from cervix uteri.


Carcinoma of the Uterine Cervix Cancer cell line derived from lymph node.


Cancer cell line derived from liver of a donor with HBL.


Pediatric Hepatoblastoma Finite cell line from liver.


Cancer cell line derived from a Hepatoblastoma patient's liver.


Finite cell line from a Hepatoblastoma patient's liver.


Cancer cell line derived from a Lymphangiectasia patient's pleural effusion.


RAD Finite cell line from skin organ.


Finite cell line derived from a Dyschromatosis symmetrica hereditaria patient's skin organ.


Transformed cell line from portion of blood of a donor with Infectious Mononucleosis.


Oat Cell Carcinoma of the Stomach Cancer cell line derived from stomach.


Finite cell line from a Ehlers-Danlos Syndrome, Type III patient's entire skin.


Transformed cell line from a Ehlers-Danlos Syndrome, Type III patient's portion of blood.


Finite cell line from skin of arm of a patient with Ehlers-Danlos Syndrome, Type III.


Finite cell line from a Hypermobile Ehlers-Danlos syndrome patient's entire skin.


Hypermobile Ehlers-Danlos syndrome Transformed cell line from vertebrate blood.


Finite cell line derived from skin of arm of a Hypermobile Ehlers-Danlos syndrome patient.


Ehlers-Danlos Syndrome, Type VII Finite cell line from entire skin.


Finite cell line derived from entire skin of a Arthrochalasia Ehlers-Danlos syndrome donor.


FAB M6 Cancer cell line derived from vertebrate blood.


Carcinoma of Endometrium Cancer cell line from ascitic fluid.


Cancer cell line from a CARCINOMA, ENDOMETRIAL, MALIGNANT patient's lymph node.


Cancer cell line from a Endometrial Carcinoma patient's tunica mucosa uteri.


Cancer cell line from mammary part of chest of a Duct Adenocarcinoma patient.


Cancer cell line derived from pleural effusion of a patient with Ductal Carcinoma of the Breast.


Cancer cell line derived from a Duct Carcinoma donor's axillary node.


Cancer cell line derived from female organism reproductive system gonada of a donor with Ovarian Serous Cystadenocarcinoma.


Ovarian Serous Cystadenocarcinoma Cancer cell line derived from ascitic fluid.


Cancer cell line derived from ascitic fluid of a cholangiosarcoma donor.


Cancer cell line from a Cholangiocarcinoma donor's bile duct.


Cholangiocarcinoma, intrahepatic and extrahepatic bile ducts (adenocarcinoma) Cancer cell line from extrahepatic bile duct.


M5b Adult Acute Differentiated Monocytic Leukemia Cancer cell line from portion of blood.


Cancer cell line derived from a Acute Monocytic Leukemia patient's pleural effusion.


Cancer cell line derived from a Acute Monocytic Leukemia patient's medulla ossea.


Cancer cell line derived from vertebrate blood of a Childhood Chronic Myelogenous Leukemia, BCR::ABL1 Positive donor.


Cancer cell line from a Childhood Chronic Myeloid Leukemia patient's medulla ossea.


Cancer cell line derived from a Chronic Eosinophilic Leukemia donor's vertebrate blood.


Cancer cell line derived from a Chronic eosinophilic leukemia patient's vertebrate blood.


Ovarian Clear Cell Adenocarcinoma Cancer cell line derived from female reproductive system gonad.


Cancer cell line derived from a Ovarian Clear Cell Adenocarcinoma patient's ascitic fluid.


Cancer cell line from lymph node of a Ovarian Clear Cell Adenocarcinoma donor.


Cancer cell line derived from a Ovarian Clear Cell Adenocarcinoma donor's pleural effusion.


Ovarian Clear Cell Adenocarcinoma Cancer cell line from spleen.


Ovarian Clear Cell Adenocarcinoma Cancer cell line from os coxae.


Cancer cell line from a Clear cell adenocarcinoma of the ovary patient's gonad of female organism reproductive system.


Cancer cell line from ascitic fluid of a patient with Clear cell adenocarcinoma of the ovary.


Cancer cell line from a Clear cell adenocarcinoma of the ovary donor's lymph node.


Cancer cell line from pleural effusion of a patient with Clear cell adenocarcinoma of the ovary.


Clear cell adenocarcinoma of the ovary Cancer cell line derived from spleen.


Clear cell adenocarcinoma of the ovary Cancer cell line from hip bone.


Endometrial Stromal Sarcoma Cancer cell line from tunica mucosa uteri.


Cancer cell line derived from a Endometrial stromal sarcoma donor's tunica mucosa (endometrium).


Fanconi Anemia, Complementation Group F Transformed cell line derived from vertebrate blood.


Fanconi Anemia, Complementation Group N Transformed cell line from entire skin.


Transformed cell line from a Fanconi Anemia, Complementation Group G donor's entire skin.


Finite cell line derived from entire skin of a Fanconi Anemia, Complementation Group G donor.


Transformed cell line derived from portion of blood of a donor with Fanconi Anemia, Complementation Group G.


myelodysplasia Cancer cell line from vertebrate blood.


Cancer cell line derived from pleural effusion of a patient with preleukemia.


Cancer cell line derived from medulla ossea of a donor with Smoldering Leukemia.


Squamous Cell Carcinoma of the Hypopharynx Cancer cell line from laryngopharynx.


Cancer cell line from laryngopharynx of a donor with Squamous cell carcinoma of the hypopharynx.


Cancer cell line from a Anaplastic Large Cell Lymphoma, ALK-Negative donor's vertebrate blood.


Cancer cell line derived from portion of blood of a patient with ALK-negative anaplastic large cell lymphoma.


Cancer cell line derived from ascitic fluid of a donor with Hepatocellular Cancer.


Cancer cell line derived from a Adult Primary Liver Cell Carcinoma patient's liver.


Cancer cell line from a Adult hepatocellular carcinoma donor's ascitic fluid.


Cancer cell line derived from a Adult hepatocellular carcinoma patient's liver.


Finite cell line from skin organ of a Mucopolysaccharidosis Type IV patient.


Finite cell line derived from skin organ of a Mucopolysaccharidosis type 4 donor.


Finite cell line from a Pseudoxanthoma Elasticum patient's entire skin.


Follicular lymphoma, unspecified, unspecified site Cancer cell line derived from ascitic fluid.


Cancer cell line from a Follicular lymphoma patient's pleural effusion.


Cancer cell line derived from a Follicular lymphoma donor's portion of blood.


Cancer cell line derived from ascitic fluid of a donor with Follicular lymphoma.


Cancer cell line derived from a Follicular lymphoma donor's pleural effusion.


Cancer cell line from oesophagus of a donor with Adenocarcinoma Arising in Barrett's Mucosa.


Cancer cell line derived from oesophagus of a Adenocarcinoma of the esophagus donor.


Cancer cell line from esophagus distal third of a patient with Adenocarcinoma of the esophagus.


Cancer cell line derived from a Rhabdoid Tumor of the Kidney patient's kidney.


Rhabdoid tumor Cancer cell line from kidney.


Rhabdoid tumor Cancer cell line derived from liver.


Tumor of the Kidney Cancer cell line derived from kidney.


Cancer cell line derived from ascitic fluid of a donor with Cancer of Gallbladder.


Cancer cell line derived from a Gall bladder carcinoma (adeno) patient's wall of abdomen proper.


Carcinoma of Gallbladder Cancer cell line from peritoneal fluid.


Cancer cell line derived from a gallbladder cancer patient's gall bladder.


Carcinoma of gallbladder and extrahepatic biliary tract Cancer cell line derived from ascitic fluid.


Carcinoma of gallbladder and extrahepatic biliary tract Cancer cell line from lymph node.


Cancer cell line from a Carcinoma of gallbladder and extrahepatic biliary tract donor's wall of abdomen proper.


Carcinoma of gallbladder and extrahepatic biliary tract Cancer cell line from peritoneal fluid.


Cancer cell line derived from a Carcinoma of gallbladder and extrahepatic biliary tract patient's gall bladder.


Cancer cell line from portion of blood of a donor with L3 Adult ALL.


Vulvar Melanoma Cancer cell line from inguinal lymph node.


Cancer cell line from pleural effusion of a Malignant Fibroxanthoma patient.


Cancer cell line from a Undifferentiated pleomorphic sarcoma patient's pleural effusion.


Telomerase immortalized cell line from kidney of a Hereditary Glomangioma patient.


Telomerase immortalized cell line derived from a Glomuvenous malformation donor's kidney.


Cancer cell line from a Acute lymphoid leukemia donor's medulla ossium.


Acute lymphoblastic leukemia Cancer cell line from portion of blood.


Acute lymphoblastic leukemia Cancer cell line derived from medulla ossium.


PKU Finite cell line from skin organ.


Transformed cell line derived from portion of blood of a donor with phenylketonuria.


Finite cell line from skin organ of a Phenylketonuria donor.


Phenylketonuria Transformed cell line from portion of blood.


Finite cell line derived from a 46,XY Sex Reversal 1 donor's gonada.


46,XY complete gonadal dysgenesis Finite cell line from gonada.


Finite cell line derived from entire skin of a Propionic Acidemia patient.


Transformed cell line derived from portion of blood of a donor with Propionic Acidemia.


Propionic Acidemia Finite cell line from late embryo.


Finite cell line from a Propionic acidemia donor's entire skin.


Propionic acidemia Transformed cell line from portion of blood.


Finite cell line derived from a Propionic acidemia patient's late embryo.


Canavan Disease Finite cell line from brain.


Finite cell line from skin organ of a Spongy Degeneration of Central Nervous System patient.


Finite cell line from preputial skin of a donor with Canavan Disease.


Finite cell line derived from brain of a Canavan disease patient.


Finite cell line from a Canavan disease patient's entire skin.


Canavan disease Finite cell line derived from foreskin of penis.


Nephropathic Cystinosis Finite cell line derived from skin organ.


Finite cell line from late embryo of a patient with Nephropathic Cystinosis.


Finite cell line from a Nephropathic Cystinosis patient's amniotic fluid.


Finite cell line derived from lung primordium of a donor with Nephropathic Cystinosis.


Infantile nephropathic cystinosis Finite cell line derived from entire skin.


Finite cell line derived from a Infantile nephropathic cystinosis donor's late embryo.


Infantile nephropathic cystinosis Finite cell line derived from amniotic fluid.


Finite cell line from a Infantile nephropathic cystinosis patient's lung primordium.


Fabry's Disease Transformed cell line derived from portion of blood.


Finite cell line derived from skin of arm of a patient with Alpha-Galactosidase A Deficiency.


Finite cell line derived from a Angiokeratoma Corporis Diffusum patient's amniotic fluid.


Transformed cell line from a Fabry disease donor's vertebrate blood.


Finite cell line derived from skin of arm of a Fabry disease donor.


Fabry disease Finite cell line derived from amniotic fluid.


Sly Syndrome Finite cell line derived from skin organ.


Finite cell line from entire skin of a Mucopolysaccharidosis type 7 patient.


Finite cell line derived from skin organ of a 49,XXXXY Syndrome patient.


49,XXXXY syndrome Finite cell line from skin organ.


Metachromatic Leukodystrophy Transformed cell line from portion of blood.


Finite cell line from skin of arm of a Metachromatic Leukodystrophy patient.


Finite cell line derived from a Metachromatic Leukodystrophy patient's amniotic fluid.


Transformed cell line derived from portion of blood of a patient with Metachromatic leukodystrophy.


Finite cell line derived from skin of arm of a Metachromatic leukodystrophy donor.


Metachromatic leukodystrophy Finite cell line from amniotic fluid.


Methylmalonic Aciduria, cblA Type Finite cell line derived from entire skin.


Finite cell line derived from a Vitamin B12-responsive methylmalonic acidemia type cblA donor's skin organ.


Kinky Hair Syndrome Finite cell line derived from skin organ.


Transformed cell line derived from a Menkes Kinky Hair Syndrome donor's portion of blood.


Finite cell line derived from a Menkes disease donor's entire skin.


Menkes disease Transformed cell line derived from portion of blood.


Glycogen Storage Disease Type II Finite cell line from entire skin.


Glycogen Storage Disease Type II Transformed cell line from entire skin.


Glycogen Storage Disease Type II Transformed cell line derived from vertebrate blood.


Finite cell line derived from entire skin of a donor with Glycogen storage disease due to acid maltase deficiency.


Glycogen storage disease due to acid maltase deficiency Transformed cell line from entire skin.


Transformed cell line from portion of blood of a Glycogen storage disease due to acid maltase deficiency patient.


Finite cell line from a Tyrosinemia Type I donor's skin organ.


Tyrosinemia type 1 Finite cell line derived from skin organ.


Fucosidosis Finite cell line derived from entire skin.


Fucosidosis Transformed cell line from vertebrate blood.


Finite cell line from a Fucosidosis patient's skin organ.


Transformed cell line from portion of blood of a donor with Fucosidosis.


Finite cell line from entire skin of a Fanconi Anemia donor.


Transformed cell line derived from a Pancytopenia, Congenital patient's skin organ.


Transformed cell line derived from a Fanconi Anemia donor's vertebrate blood.


Primary Erythroid Hypoplasia Finite cell line derived from skin of arm.


Finite cell line from skin of antebrachial region of a patient with Fanconi's anemia.


Fanconi Anemia, Complementation Group A Finite cell line derived from entire skin.


Transformed cell line derived from a Fanconi Anemia, Complementation Group A donor's vertebrate blood.


Finite cell line from a Fanconi Anemia, Complementation Group A patient's skin of arm.


Finite cell line derived from a Fanconi Anemia, Complementation Group A donor's anterior thoracic region zone of skin.


Fanconi Anemia, Complementation Group A Transformed cell line from zone of skin of front of thorax.


Finite cell line from a Fanconi Anemia, Complementation Group A donor's skin of lower arm.


Finite cell line from a Gaucher Disease patient's entire skin.


Transformed cell line derived from a Glucosylceramide Beta-Glucosidase Deficiency donor's portion of blood.


Glucosylceramide Beta-Glucosidase Deficiency Finite cell line derived from skin of arm.


Finite cell line derived from skin organ of a patient with Gaucher disease.


Gaucher disease Transformed cell line from vertebrate blood.


Finite cell line derived from a Gaucher disease patient's skin of arm.


Finite cell line derived from a Lesch-Nyhan Syndrome patient's entire skin.


Transformed cell line from a Lesch-Nyhan Syndrome patient's skin organ.


Transformed cell line from a Lesch-Nyhan Syndrome patient's vertebrate blood.


Lesch-Nyhan Syndrome Finite cell line derived from skin of arm.


Finite cell line derived from kidney of a donor with Lesch-Nyhan Syndrome.


Finite cell line from a Lesch-Nyhan Syndrome donor's amniotic fluid.


Finite cell line derived from a Lesch-Nyhan Syndrome donor's lung primordium.


Lesch-Nyhan syndrome Finite cell line from entire skin.


Transformed cell line from a Lesch-Nyhan syndrome patient's entire skin.


Transformed cell line from a Lesch-Nyhan syndrome patient's portion of blood.


Finite cell line from a Lesch-Nyhan syndrome patient's skin of arm.


Finite cell line from a Lesch-Nyhan syndrome patient's kidney.


Finite cell line derived from amniotic fluid of a patient with Lesch-Nyhan syndrome.


Lesch-Nyhan syndrome Finite cell line from lung primordium.


Finite cell line derived from skin organ of a patient with Hurler Syndrome.


Transformed cell line derived from a Mucopolysaccharidosis Type IH patient's vertebrate blood.


Finite cell line derived from a Hurler syndrome donor's skin organ.


Transformed cell line derived from vertebrate blood of a Hurler syndrome patient.


Finite cell line derived from skin organ of a patient with Trisomy 8.


tri8 Finite cell line from late embryo.


Finite cell line derived from a Total autosomal trisomy syndrome patient's entire skin.


Transformed cell line derived from a Total autosomal trisomy syndrome patient's vertebrate blood.


Total autosomal trisomy syndrome Finite cell line from late embryo.


Finite cell line derived from funiculus umbilicalis of a Total autosomal trisomy syndrome donor.


Total autosomal trisomy syndrome Finite cell line derived from amnios.


Total autosomal trisomy syndrome Finite cell line from chorionic villus.


Finite cell line derived from a Type IIa Hyperlipidemia donor's skin organ.


Transformed cell line derived from a Hyperlipoproteinemia, Type IIa patient's vertebrate blood.


Finite cell line from a FH patient's skin of arm.


Finite cell line from skin organ of a donor with Homozygous familial hypercholesterolemia.


Transformed cell line derived from a Homozygous familial hypercholesterolemia donor's portion of blood.


Finite cell line derived from skin of arm of a Homozygous familial hypercholesterolemia patient.


Fibrodysplasia Ossificans Progressiva Finite cell line derived from skin of arm.


Finite cell line from a Fibrodysplasia Ossificans Progressiva donor's shoulder zone of skin.


Finite cell line derived from a Fibrodysplasia ossificans progressiva patient's skin of arm.


Finite cell line derived from a Fibrodysplasia ossificans progressiva donor's shoulder zone of skin.


Finite cell line derived from entire skin of a Tay-Sachs Disease donor.


Transformed cell line from portion of blood of a donor with Tay-Sachs Disease.


Finite cell line from a Tay-Sachs Disease donor's skin of upper leg.


Tay-Sachs disease Finite cell line from pericardium.


Tay-Sachs disease Finite cell line from entire skin.


Transformed cell line from portion of blood of a patient with Tay-Sachs disease.


Tay-Sachs disease Finite cell line derived from skin of upper leg.


Finite cell line derived from pericardium of a donor with Tay-Sachs disease.


Maroteaux-Lamy Syndrome Finite cell line from entire skin.


Mucopolysaccharidosis Type VI Transformed cell line from portion of blood.


Finite cell line from a Mucopolysaccharidosis Type VI donor's skin of arm.


Finite cell line from entire skin of a donor with Mucopolysaccharidosis type 6.


Transformed cell line from vertebrate blood of a Mucopolysaccharidosis type 6 patient.


Finite cell line derived from a Mucopolysaccharidosis type 6 patient's skin of arm.


Finite cell line derived from skin organ of a Glucose-6 Phosphatase Deficiency donor.


Hepatorenal Glycogenosis Transformed cell line from portion of blood.


Finite cell line derived from a Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia donor's skin organ.


Transformed cell line derived from a Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia patient's portion of blood.


Glycogen Storage Disease Type III Finite cell line from skin organ.


Finite cell line derived from entire skin of a Glycogen storage disease due to glycogen debranching enzyme deficiency patient.


Finite cell line derived from a Homocystinuria donor's skin organ.


Transformed cell line derived from a Homocystinuria patient's portion of blood.


Finite cell line derived from a Homocystinuria patient's amniotic fluid.


Homocystinuria due to cystathionine beta-synthase deficiency Finite cell line from entire skin.


Transformed cell line derived from portion of blood of a Homocystinuria due to cystathionine beta-synthase deficiency donor.


Finite cell line derived from a Homocystinuria due to cystathionine beta-synthase deficiency patient's amniotic fluid.


Finite cell line derived from a Riley-Day Syndrome patient's entire skin.


HSAN 3 Transformed cell line derived from vertebrate blood.


Familial dysautonomia Finite cell line derived from entire skin.


Transformed cell line derived from a Familial dysautonomia donor's portion of blood.


Transformed cell line from portion of blood of a donor with asthma.


Alpha-Mannosidosis Finite cell line derived from entire skin.


Finite cell line derived from skin organ of a Alpha-mannosidosis patient.


Finite cell line derived from a Mucopolysaccharidosis Type II patient's skin organ.


Hunter Syndrome Transformed cell line from vertebrate blood.


Hunter Syndrome Finite cell line derived from late embryo.


Finite cell line derived from a Mucopolysaccharidosis Type II patient's amniotic fluid.


Mucopolysaccharidosis type 2 Finite cell line derived from entire skin.


Transformed cell line from portion of blood of a patient with Mucopolysaccharidosis type 2.


Mucopolysaccharidosis type 2 Finite cell line from late embryo.


Finite cell line derived from amniotic fluid of a Mucopolysaccharidosis type 2 donor.


Finite cell line from a Thanatophoric Dysplasia patient's pulmo.


Finite cell line derived from a Thanatophoric Dysplasia donor's skin organ.


Thanatophoric Dysplasia Finite cell line derived from muscle organ.


Finite cell line from late embryo of a donor with Thanatophoric Dysplasia.


Finite cell line derived from a Thanatophoric Dysplasia patient's spleen.


Finite cell line derived from chondrogenic tissue of a patient with Thanatophoric Dysplasia.


Finite cell line from a Thanatophoric dysplasia donor's pulmo.


Finite cell line derived from a Thanatophoric dysplasia donor's entire skin.


Finite cell line derived from a Thanatophoric dysplasia patient's muscle organ.


Thanatophoric dysplasia Finite cell line from late embryo.


Finite cell line derived from spleen of a patient with Thanatophoric dysplasia.


Finite cell line from cartilage tissue of a patient with Thanatophoric dysplasia.


Finite cell line derived from skin organ of a patient with MPS III A.


Transformed cell line derived from a MPS III A donor's vertebrate blood.


Finite cell line derived from entire skin of a patient with Sanfilippo syndrome type A.


Transformed cell line from a Sanfilippo syndrome type A patient's portion of blood.


Transformed cell line derived from a Sporadic Retinoblastoma patient's entire skin.


Sporadic Retinoblastoma Finite cell line derived from skin organ.


Transformed cell line from portion of blood of a Sporadic Retinoblastoma patient.


Finite cell line from skin of arm of a donor with Sporadic Retinoblastoma.


Finite cell line from a Sporadic Retinoblastoma donor's wall of conjunctival sac.


Transformed cell line derived from entire skin of a patient with Retinoblastoma.


Finite cell line derived from a Retinoblastoma patient's skin organ.


Transformed cell line derived from vertebrate blood of a Retinoblastoma donor.


Finite cell line from skin of arm of a Retinoblastoma patient.


Cancer cell line derived from a Retinoblastoma patient's lymph node of neck.


Cancer cell line from a Retinoblastoma donor's orbit of skull.


Retinoblastoma Finite cell line from wall of conjunctival sac.


Retinoblastoma Cancer cell line from CSF.


Cancer cell line derived from a Retinoblastoma donor's eye.


Cancer cell line derived from bulbus oculi of a donor with Retinoblastoma.


Finite cell line from a Acute Intermittent Porphyria patient's skin organ.


Transformed cell line from portion of blood of a donor with Acute Intermittent Porphyria.


Finite cell line from skin organ of a Acute intermittent porphyria donor.


Transformed cell line from vertebrate blood of a patient with Acute intermittent porphyria.


Finite cell line derived from a Scleromyxedema donor's leg zone of skin.


Finite cell line from a Scleromyxedema donor's gums.


Scleromyxedema Finite cell line from leg zone of skin.


Finite cell line derived from a Scleromyxedema donor's gums.


Finite cell line derived from a Hurler-Scheie Syndrome donor's entire skin.


Transformed cell line derived from a Hurler-Scheie Syndrome patient's vertebrate blood.


Finite cell line from skin organ of a donor with Hurler-Scheie syndrome.


Transformed cell line derived from vertebrate blood of a donor with Hurler-Scheie syndrome.


Finite cell line derived from skin organ of a patient with MODY1.


MODY1 Transformed cell line from vertebrate blood.


Finite cell line from a MODY patient's skin organ.


Transformed cell line from a MODY donor's vertebrate blood.


Retinoblastoma, NOS Finite cell line derived from skin organ.


Transformed cell line from a RETINOBLASTOMA, MALIGNANT patient's portion of blood.


retinoblastoma Cancer cell line derived from lymph node of neck.


Cancer cell line derived from a retinoblastoma patient's bony orbit.


Finite cell line derived from a RB patient's tunica conjunctiva.


Cancer cell line from eye of a patient with Retinoblastoma.


Cancer cell line from a Retinoblastoma, NOS patient's eye globe.


NCMD Finite cell line from skin organ.


North Carolina Macular Dystrophy Transformed cell line from portion of blood.


Finite cell line from a MCDR1 patient's cornea of camera-type eye.


Finite cell line derived from skin organ of a patient with North Carolina macular dystrophy.


Transformed cell line derived from vertebrate blood of a donor with North Carolina macular dystrophy.


Finite cell line derived from a North Carolina macular dystrophy patient's cornea of camera-type eye.


Finite cell line derived from a Xeroderma Pigmentosum Group E donor's skin organ.


Transformed cell line from vertebrate blood of a XP-E patient.


MODY Transformed cell line from vertebrate blood.


Finite cell line from a MPS I S donor's entire skin.


Finite cell line derived from a Scheie syndrome donor's entire skin.


Finite cell line from female reproductive system gonad of a patient with Dermoid Cyst of Ovary.


Mucopolysaccharidosis Type IVA Finite cell line derived from skin organ.


Finite cell line derived from a Mucopolysaccharidosis type 4A patient's entire skin.


Transformed cell line from a Maple Syrup Urine Disease donor's vertebrate blood.


Finite cell line from a Maple Syrup Urine Disease donor's pericardium.


Transformed cell line from a Maple syrup urine disease donor's vertebrate blood.


Finite cell line from a Maple syrup urine disease donor's pericardium.


Cutis Laxa Finite cell line derived from entire skin.


Cutis laxa Finite cell line from entire skin.


Finite cell line derived from entire skin of a Adenosine Deaminase Severe Combined Immune Deficiency patient.


Transformed cell line derived from a Adenosine Deaminase Severe Combined Immune Deficiency donor's vertebrate blood.


Severe combined immunodeficiency due to adenosine deaminase deficiency Finite cell line from skin organ.


Transformed cell line derived from a Severe combined immunodeficiency due to adenosine deaminase deficiency donor's portion of blood.


Finite cell line from skin organ of a Mucopolysaccharidosis Type IIIB patient.


Transformed cell line from vertebrate blood of a donor with Mucopolysaccharidosis Type IIIB.


Finite cell line derived from skin organ of a Sanfilippo syndrome type B donor.


Transformed cell line from a Sanfilippo syndrome type B donor's vertebrate blood.


Transformed cell line derived from a Abetalipoproteinemia patient's vertebrate blood.


Transformed cell line from vertebrate blood of a donor with Abetalipoproteinemia.


Transformed cell line from a Cystathioninuria donor's portion of blood.


Transformed cell line derived from a Hyperlipoproteinemia, Type IIb patient's vertebrate blood.


Familial chylomicronemia syndrome Transformed cell line from portion of blood.


Finite cell line derived from a Schizophrenia, unspecified patient's entire skin.


Transformed cell line derived from portion of blood of a schizophrenia patient.


Finite cell line derived from skin of arm of a Schizophrenia patient.


Finite cell line derived from a Schizophrenia patient's liver.


Finite cell line from skin organ of a donor with Anorexia nervosa.


Transformed cell line derived from portion of blood of a anorexia nervosa patient.


Finite cell line derived from skin of iliac crest region of a donor with Anorexia Nervosa.


Finite cell line derived from skin organ of a Gorlin Syndrome donor.


Transformed cell line from portion of blood of a basal cell nevus syndrome donor.


Finite cell line derived from a Gorlin syndrome donor's skin organ.


Gorlin syndrome Transformed cell line from vertebrate blood.


Finite cell line derived from a Hypophosphatasia donor's entire skin.


Transformed cell line derived from a Hypophosphatasia donor's vertebrate blood.


Finite cell line from a Hypophosphatasia patient's late embryo.


Finite cell line from amniotic fluid of a donor with Hypophosphatasia.


Hypophosphatasia Finite cell line derived from skin organ.


Hypophosphatasia Transformed cell line derived from vertebrate blood.


Hypophosphatasia Finite cell line from late embryo.


Finite cell line derived from a Hypophosphatasia patient's amniotic fluid.


Finite cell line derived from a Inclusion-cell Disease donor's entire skin.


Finite cell line from late embryo of a donor with Mucolipidosis Type II.


Mucolipidosis type II Finite cell line from entire skin.


Finite cell line derived from late embryo of a patient with Mucolipidosis type II.


Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness Syndrome Finite cell line from skin organ.


DIDMOAD Transformed cell line derived from vertebrate blood.


Finite cell line from a Wolfram syndrome patient's skin organ.


Wolfram syndrome Transformed cell line derived from portion of blood.


Transformed cell line derived from a Inosine Triphosphatase Deficiency patient's vertebrate blood.


Transformed cell line from a ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement patient's vertebrate blood.


Neurofibromatosis Cancer cell line from brain.


Finite cell line derived from entire skin of a patient with neurofibromatosis type 1.


NF1 Transformed cell line from portion of blood.


Cancer cell line from hindlimb stylopod of a neurofibromatosis type 1 patient.


Neurofibromatosis type 1 Cancer cell line from brain.


Finite cell line derived from skin organ of a patient with Neurofibromatosis type 1.


Transformed cell line derived from a Neurofibromatosis type 1 donor's portion of blood.


Neurofibromatosis type 1 Cancer cell line derived from upper leg.


Finite cell line derived from entire skin of a patient with Tuberous Sclerosis 1.


Tuberous Sclerosis 1 Transformed cell line derived from portion of blood.


Tuberous sclerosis complex Finite cell line from skin organ.


Transformed cell line derived from portion of blood of a patient with Tuberous sclerosis complex.


Finite cell line from gonada of a DYSGENETIC_GONAD donor.


Finite cell line from skin organ of a patient with Neuraminidase Deficiency.


Finite cell line from entire skin of a donor with Sialidosis type 2.


Finite cell line derived from entire skin of a Androgen Resistance Syndrome patient.


Finite cell line derived from skin of upper leg of a donor with Androgen Insensitivity Syndrome.


Finite cell line from zone of skin of abdomen of a donor with Testicular Feminization Syndrome.


Androgen Insensitivity Syndrome Finite cell line derived from gonada.


Finite cell line from a Androgen Insensitivity Syndrome donor's skin of external genitalia.


Androgen insensitivity syndrome Finite cell line from skin organ.


Finite cell line from a Androgen insensitivity syndrome patient's skin of upper leg.


Androgen insensitivity syndrome Finite cell line derived from abdomen skin.


Finite cell line from a Androgen insensitivity syndrome donor's gonada.


Finite cell line from skin of external genitalia of a Androgen insensitivity syndrome patient.


Finite cell line from a Xeroderma Pigmentosum, Complementation Group C donor's entire skin.


Transformed cell line derived from portion of blood of a Xeroderma Pigmentosum Group C donor.


Finite cell line from a Xeroderma Pigmentosum Group C donor's skin of arm.


Cancer cell line derived from a XP-C patient's testicle.


Xeroderma Pigmentosum Group C Transformed cell line derived from amniotic fluid.


Xeroderma Pigmentosum, Complementation Group C Finite cell line from tongue.


Finite cell line from a Campomelic Dysplasia donor's gonada.


Finite cell line derived from a Campomelic dysplasia patient's gonada.


Transformed cell line derived from a Sea-Blue Histiocyte Syndrome patient's vertebrate blood.


Transformed cell line from vertebrate blood of a patient with Sea-blue histiocytosis.


Finite cell line derived from a Ataxia with Isolated Vitamin E Deficiency patient's skin organ.


Ataxia with vitamin E deficiency Finite cell line derived from skin organ.


Finite cell line derived from late embryo of a 47,XYY Syndrome donor.


Finite cell line from amniotic fluid of a XYY Syndrome patient.


47,XYY syndrome Finite cell line derived from late embryo.


Finite cell line from amniotic fluid of a 47,XYY syndrome patient.


Transformed cell line from portion of blood of a Amyloidosis, Familial donor.


Transformed cell line derived from a Hereditary ATTR amyloidosis donor's portion of blood.


Transformed cell line from vertebrate blood of a donor with Argininemia.


Transformed cell line derived from a Argininemia patient's vertebrate blood.


Transformed cell line from portion of blood of a donor with Hereditary Persistence of Fetal Hemoglobin.


Transformed cell line derived from portion of blood of a donor with Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome.


Transformed cell line derived from portion of blood of a patient with Autosomal Dominant Torsion Dystonia 1.


Early-onset generalized limb-onset dystonia Transformed cell line from portion of blood.


Thalassemia Major Transformed cell line from portion of blood.


Transformed cell line derived from portion of blood of a donor with Beta-thalassemia major.


21-Hydroxylase Deficieny Transformed cell line from vertebrate blood.


Transformed cell line from a Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency donor's portion of blood.


Transformed cell line from portion of blood of a DYT2 patient.


Transformed cell line derived from portion of blood of a Primary dystonia, DYT2 type patient.


Finite cell line from a Becker's Muscular Dystrophy donor's entire skin.


Becker's Muscular Dystrophy Transformed cell line from vertebrate blood.


Finite cell line derived from a Becker patient's skin of arm.


Finite cell line derived from a Becker muscular dystrophy donor's skin organ.


Transformed cell line from vertebrate blood of a Becker muscular dystrophy patient.


Finite cell line derived from a Becker muscular dystrophy donor's skin of arm.


Transformed cell line derived from portion of blood of a patient with Hereditary Coproporphyria.


Transformed cell line from portion of blood of a donor with Hereditary coproporphyria.


Transformed cell line from a Variegate Porphyria donor's portion of blood.


Transformed cell line derived from portion of blood of a Variegate porphyria patient.


Farber Lipogranulomatosis Finite cell line derived from entire skin.


Transformed cell line from a Farber Lipogranulomatosis donor's portion of blood.


Finite cell line derived from vertebrate dermis of a Farber Lipogranulomatosis patient.


Finite cell line derived from a Farber disease patient's entire skin.


Transformed cell line derived from a Farber disease donor's portion of blood.


Farber disease Finite cell line derived from vertebrate dermis.


Finite cell line from a Duchenne Muscular Dystrophy patient's entire skin.


Transformed cell line from vertebrate blood of a Duchenne patient.


Finite cell line from a Duchenne Muscular Dystrophy donor's skin of arm.


Finite cell line from a Duchenne donor's late embryo.


Duchenne muscular dystrophy Finite cell line derived from skin organ.


Transformed cell line derived from vertebrate blood of a donor with Duchenne muscular dystrophy.


Duchenne muscular dystrophy Finite cell line derived from skin of arm.


Finite cell line from a Duchenne muscular dystrophy patient's late embryo.


Finite cell line from a sickle cell anemia patient's skin organ.


Transformed cell line from portion of blood of a patient with Sickle-cell Disorders.


Finite cell line from entire skin of a donor with Sickle cell anemia.


Transformed cell line derived from a Sickle cell anemia patient's portion of blood.


Transformed cell line derived from a Chediak-Higashi Syndrome patient's portion of blood.


Transformed cell line derived from vertebrate blood of a Chédiak-Higashi syndrome patient.


GM1 Gangliosidosis Finite cell line derived from entire skin.


Finite cell line from entire skin of a donor with GM1 gangliosidosis.


A1AD Transformed cell line from vertebrate blood.


Alpha-1 Antitrypsin Deficiency Finite cell line derived from abdomen skin.


Finite cell line from a A1AD patient's liver.


Transformed cell line from vertebrate blood of a Alpha-1-antitrypsin deficiency donor.


Finite cell line from abdominal skin of a Alpha-1-antitrypsin deficiency patient.


Finite cell line derived from a Alpha-1-antitrypsin deficiency donor's liver.


Mucolipidosis IV Transformed cell line derived from vertebrate blood.


Finite cell line from a Mucolipidosis IV patient's amniotic fluid.


Transformed cell line derived from vertebrate blood of a donor with Mucolipidosis type IV.


Finite cell line derived from amniotic fluid of a Mucolipidosis type IV patient.


Transformed cell line from portion of blood of a patient with Hemoglobin Lepore Syndrome.


Transformed cell line derived from a Hemoglobin Lepore-beta-thalassemia syndrome donor's portion of blood.


Transformed cell line from a Carnosinase Deficiency patient's portion of blood.


Transformed cell line from vertebrate blood of a Carnosinase deficiency patient.


Finite cell line from a Turcot Syndrome patient's skin organ.


Transformed cell line from portion of blood of a Turcot Syndrome patient.


Finite cell line from a Turcot syndrome with polyposis patient's skin organ.


Transformed cell line from vertebrate blood of a patient with Turcot syndrome with polyposis.


Finite cell line derived from a Sialidosis type 1 patient's entire skin.


Transformed cell line derived from a Carbonic Anhydrase I Deficiency donor's vertebrate blood.


Transformed cell line from a Mental Retardation donor's portion of blood.


Nasal Polyp Finite cell line from nasal fossa.


Finite cell line derived from a 3-Oxo-5 Alpha-Steroid Delta 4-Dehydrogenase Deficiency donor's skin of external genitalia.


Finite cell line derived from skin of external genitalia of a donor with 46,XY difference of sex development due to 5-alpha-reductase 2 deficiency.


Epidermodysplasia Verruciformis Finite cell line from entire skin.


Finite cell line derived from a Inherited epidermodysplasia verruciformis donor's skin organ.


Transformed cell line from a Argininosuccinic Aciduria patient's vertebrate blood.


Transformed cell line derived from a Argininosuccinic aciduria donor's vertebrate blood.


Ichthyosis, X-linked Finite cell line derived from skin organ.


Transformed cell line from entire skin of a X-Linked Ichthyosis patient.


Finite cell line from a X-linked ichthyosis syndrome patient's entire skin.


Transformed cell line from entire skin of a donor with X-linked ichthyosis syndrome.


Finite cell line derived from entire skin of a Alpha Thalassemia patient.


Alpha Thalassemia Finite cell line from muscle organ.


Finite cell line derived from lung primordium of a Alpha Thalassemia patient.


Finite cell line derived from a Alpha-thalassemia patient's entire skin.


Alpha-thalassemia Finite cell line from muscle organ.


Finite cell line derived from a Alpha-thalassemia donor's lung primordium.


Krabbe Disease Finite cell line from entire skin.


Globoid Cell Leukodystrophy Transformed cell line from portion of blood.


Globoid Cell Leukodystrophy Finite cell line derived from late embryo.


Krabbe Disease Finite cell line from presumptive brain.


Finite cell line derived from a Krabbe Disease patient's spleen mesenchyme.


Krabbe disease Finite cell line from skin organ.


Transformed cell line derived from a Krabbe disease donor's portion of blood.


Finite cell line derived from late embryo of a donor with Krabbe disease.


Krabbe disease Finite cell line from brain rudiment.


Finite cell line from splenic primordium of a Krabbe disease donor.


Transformed cell line derived from vertebrate blood of a Congenital Sucrase-Isomaltase Deficiency donor.


Transformed cell line from a Congenital sucrase-isomaltase deficiency patient's portion of blood.


Finite cell line from a Myopathy due to Myoadenylate Deaminase Deficiency donor's skin organ.


Finite cell line from a Myopathy due to Myoadenylate Deaminase Deficiency donor's muscle organ.


Finite cell line from entire skin of a patient with Adenosine monophosphate deaminase deficiency.


Finite cell line from a Adenosine monophosphate deaminase deficiency patient's muscle organ.


Finite cell line derived from a Lysosomal Acid Lipase Deficiency patient's skin organ.


Wolman disease Finite cell line derived from entire skin.


Finite cell line derived from a Wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome donor's entire skin.


Transformed cell line from vertebrate blood of a donor with 11p Partial Monosomy Syndrome.


Finite cell line derived from a WAGR syndrome donor's entire skin.


WAGR syndrome Transformed cell line from portion of blood.


Niemann-Pick Disease, Type C1 Finite cell line derived from skin organ.


Transformed cell line from a Niemann-Pick Disease, Type C1 patient's portion of blood.


Niemann-Pick disease type C Finite cell line derived from entire skin.


Niemann-Pick disease type C Transformed cell line from portion of blood.


PFKM Deficiency Transformed cell line derived from portion of blood.


Glycogen storage disease due to muscle phosphofructokinase deficiency Transformed cell line from portion of blood.


Finite cell line from entire skin of a donor with Anetoderma.


Primary anetoderma Finite cell line from skin organ.


Fragile X Syndrome Finite cell line from entire skin.


Transformed cell line derived from a Fragile X Syndrome donor's vertebrate blood.


Finite cell line derived from a Fragile X Syndrome donor's kidney.


Finite cell line derived from a Fragile X Syndrome donor's lung primordium.


Finite cell line from allantoic placenta of a Fragile X Syndrome patient.


Finite cell line derived from skin organ of a patient with Fragile X syndrome.


Fragile X syndrome Transformed cell line derived from portion of blood.


Finite cell line from a Fragile X syndrome patient's kidney.


Finite cell line from lung primordium of a donor with Fragile X syndrome.


Fragile X syndrome Finite cell line derived from eutherian placenta.


Finite cell line derived from a Meckel-Gruber Syndrome patient's entire skin.


Meckel-Gruber Syndrome Finite cell line derived from late embryo.


Finite cell line derived from entire skin of a Meckel syndrome donor.


Finite cell line derived from a Meckel syndrome donor's late embryo.


Finite cell line derived from a Trisomy 9 donor's skin organ.


Trisomy 9 Transformed cell line derived from portion of blood.


Finite cell line from a Trisomy 9 patient's late embryo.


Finite cell line from a Trisomy 9 patient's funiculus umbilicalis.


Finite cell line derived from skin organ of a donor with Ring Chromosome.


Transformed cell line derived from a Supernumerary Circular Chromosome patient's vertebrate blood.


Finite cell line from a Idiopathic Basal Ganglia Calcification 1 donor's entire skin.


Finite cell line from entire skin of a patient with Bilateral striopallidodentate calcinosis.


Finite cell line derived from a Multiple Sulfatase Deficiency Disease donor's entire skin.


Transformed cell line from a Multiple Sulfatase Deficiency Disease donor's portion of blood.


Finite cell line from skin organ of a Multiple sulfatase deficiency donor.


Transformed cell line from a Multiple sulfatase deficiency patient's vertebrate blood.


Finite cell line from a Mucopolysaccharidosis Type IVB donor's entire skin.


Finite cell line from entire skin of a Mucopolysaccharidosis type 4B donor.


Niemann-Pick Disease, Type A Finite cell line from skin organ.


Finite cell line derived from late embryo of a donor with Niemann-Pick Disease, Type A.


Finite cell line from a Infantile neurovisceral acid sphingomyelinase deficiency patient's entire skin.


Finite cell line derived from late embryo of a Infantile neurovisceral acid sphingomyelinase deficiency donor.


Finite cell line from a Lowe Syndrome donor's late embryo.


Oculocerebrorenal syndrome of Lowe Finite cell line derived from late embryo.


Ichthyosis Finite cell line derived from skin organ.


Transformed cell line derived from a Ichthyosis patient's vertebrate blood.


Finite cell line from a Inherited ichthyosis donor's skin organ.


Inherited ichthyosis Transformed cell line from portion of blood.


Transformed cell line derived from a Coffin-Lowry Syndrome donor's vertebrate blood.


Transformed cell line derived from vertebrate blood of a donor with Coffin-Lowry syndrome.


Finite cell line derived from skin organ of a donor with Carbamoyl Phosphate Synthetase Deficiency.


Carbamoyl Phosphate Synthetase Deficiency Transformed cell line derived from portion of blood.


Finite cell line derived from a Carbamoyl-phosphate synthetase 1 deficiency patient's entire skin.


Carbamoyl-phosphate synthetase 1 deficiency Transformed cell line from portion of blood.


Transformed cell line derived from vertebrate blood of a patient with Kidney Nephroblastoma.


Cancer cell line derived from a Renal Wilms' Tumor patient's kidney.


Transformed cell line derived from portion of blood of a donor with Nephroblastoma.


Cancer cell line derived from a Nephroblastoma donor's kidney.


Transformed cell line from a Spinocerebellar Ataxia Type 7 patient's vertebrate blood.


Transformed cell line from a Spinocerebellar ataxia type 7 patient's portion of blood.


Finite cell line from late embryo of a patient with Trisomy 2.


Finite cell line derived from a Trisomy 21 donor's late embryo.


Finite cell line from amnios of a Trisomy-21 donor.


Glycogen Storage Disease Type Ib Finite cell line from skin organ.


Finite cell line from a Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib donor's skin organ.


18P Syndrome Finite cell line derived from skin organ.


Transformed cell line from a Deletion 18p Syndrome patient's portion of blood.


Monosomy 18p syndrome Finite cell line derived from entire skin.


Transformed cell line from a Monosomy 18p syndrome patient's portion of blood.


Finite cell line from skin of arm of a patient with Spinal Muscular Atrophy Type 2.


Finite cell line derived from skin of arm of a donor with Proximal spinal muscular atrophy type 2.


Friedreich ataxia Finite cell line from entire skin.


Transformed cell line from vertebrate blood of a Friedreich Ataxia patient.


Finite cell line from a Friedreich's Ataxia patient's skin of arm.


Finite cell line from skin organ of a donor with Friedreich ataxia.


Transformed cell line derived from a Friedreich ataxia donor's portion of blood.


Finite cell line derived from a Friedreich ataxia patient's skin of arm.


Finite cell line from skin organ of a donor with Retinitis Pigmentosa.


Retinitis Pigmentosa Transformed cell line from portion of blood.


Finite cell line from entire skin of a donor with Retinitis pigmentosa.


Retinitis pigmentosa Transformed cell line derived from vertebrate blood.


Leber Congenital Amaurosis Transformed cell line from vertebrate blood.


Finite cell line from a Leber Congenital Amaurosis donor's skin of buttock.


Transformed cell line from vertebrate blood of a Leber congenital amaurosis donor.


Finite cell line derived from skin of buttock of a Leber congenital amaurosis patient.


Finite cell line from skin organ of a patient with Usher Syndrome Type 1.


Transformed cell line derived from portion of blood of a donor with Usher Syndrome Type 1.


Finite cell line from skin organ of a patient with Usher syndrome type 1.


Transformed cell line from portion of blood of a Usher syndrome type 1 patient.


Transformed cell line from portion of blood of a patient with Hereditary Optic Atrophy.


Hereditary Optic Atrophy Finite cell line derived from skin of buttock.


Transformed cell line derived from a Hereditary optic neuropathy patient's portion of blood.


Hereditary optic neuropathy Finite cell line derived from skin of buttock.


Finite cell line from a Refsum Disease donor's skin organ.


Refsum Disease Transformed cell line from vertebrate blood.


Finite cell line from entire skin of a patient with Refsum disease.


Transformed cell line derived from vertebrate blood of a Refsum disease donor.


Transformed cell line from portion of blood of a donor with LGMD2A.


Transformed cell line from portion of blood of a patient with Calpain-3-related limb-girdle muscular dystrophy R1.


Finite cell line derived from entire skin of a donor with Tuberous Sclerosis 2.


Transformed cell line from a Tuberous Sclerosis 2 patient's portion of blood.


LEOPARD Syndrome Transformed cell line from vertebrate blood.


Transformed cell line from portion of blood of a donor with Noonan syndrome with multiple lentigines.


Transformed cell line from vertebrate blood of a Pterygium donor.


Transformed cell line derived from a Familial pterygium of the conjunctiva patient's portion of blood.


Finite cell line derived from a Prader-Willi-Labhart Syndrome donor's skin organ.


Transformed cell line from portion of blood of a Prader-Labhart-Willi Syndrome donor.


Finite cell line from a Prader-Willi syndrome donor's skin organ.


Prader-Willi syndrome Transformed cell line derived from vertebrate blood.


Finite cell line derived from entire skin of a donor with GSL.


Transformed cell line from portion of blood of a donor with Galactosialidosis.


Finite cell line derived from a Galactosialidosis donor's skin organ.


Galactosialidosis Transformed cell line derived from vertebrate blood.


Kearns-Sayre Syndrome Finite cell line derived from entire skin.


Kearns-Sayre Syndrome Transformed cell line from vertebrate blood.


Finite cell line from a Kearns-Sayre syndrome patient's entire skin.


Transformed cell line from portion of blood of a Kearns-Sayre syndrome patient.


Transformed cell line from portion of blood of a Albright's Hereditary Osteodystrophy with Multiple Hormone Resistance patient.


Transformed cell line from vertebrate blood of a donor with Albright hereditary osteodystrophy.


Trisomy 16 Finite cell line derived from amnios.


Finite cell line derived from a Schilder Disease patient's skin organ.


Transformed cell line from a Adrenoleukodystrophy donor's portion of blood.


Finite cell line derived from a Adrenoleukodystrophy donor's skin of arm.


X-linked cerebral adrenoleukodystrophy Finite cell line derived from entire skin.


Transformed cell line derived from a X-linked cerebral adrenoleukodystrophy patient's portion of blood.


X-linked cerebral adrenoleukodystrophy Finite cell line derived from skin of arm.


Sideroblastic Anemia Transformed cell line derived from vertebrate blood.


Sideroblastic anemia Transformed cell line from portion of blood.


Transformed cell line derived from a Phosphoglycerate Kinase 1 Deficiency patient's vertebrate blood.


Transformed cell line derived from a Glycogen storage disease due to phosphoglycerate kinase 1 deficiency donor's portion of blood.


Finite cell line from entire skin of a donor with CMTX1.


Finite cell line derived from a X-linked Charcot-Marie-Tooth disease type 1 patient's entire skin.


Finite cell line from a Tourette Syndrome patient's skin organ.


Tourette Syndrome Transformed cell line derived from vertebrate blood.


Transformed cell line derived from a Bipolar disorder, unspecified patient's portion of blood.


Bipolar Disorder Finite cell line from skin of iliac crest region.


Transformed cell line derived from vertebrate blood of a depression patient.


Finite cell line derived from skin of iliac crest region of a depression donor.


Mucopolysaccharidosis Type IIID Finite cell line derived from entire skin.


Sanfilippo syndrome type D Finite cell line derived from skin organ.


Finite cell line derived from a Charcot-Marie-Tooth Disease Type 1A patient's entire skin.


Transformed cell line derived from vertebrate blood of a donor with Charcot-Marie-Tooth Disease Type 1A.


Charcot-Marie-Tooth disease type 1A Finite cell line derived from entire skin.


Transformed cell line derived from a Charcot-Marie-Tooth disease type 1A patient's vertebrate blood.


Transformed cell line from portion of blood of a donor with Anxiety.


Anxiety Finite cell line derived from skin of iliac crest region.


Donohue Syndrome Finite cell line from skin organ.


Leprechaunism Transformed cell line derived from vertebrate blood.


Finite cell line derived from a Leprechaunism patient's skin organ.


Transformed cell line derived from a Leprechaunism donor's vertebrate blood.


Finite cell line from a Wilson Disease donor's skin organ.


Transformed cell line derived from a Wilson Disease donor's portion of blood.


Finite cell line derived from a Wilson disease donor's entire skin.


Wilson disease Transformed cell line derived from vertebrate blood.


Kartagener Syndrome Transformed cell line from portion of blood.


Transformed cell line from portion of blood of a CILD1 donor.


Transformed cell line from portion of blood of a patient with Primary ciliary dyskinesia, Kartagener type.


Finite cell line derived from skin organ of a patient with Fragile Site.


Transformed cell line from portion of blood of a Chromosome Fragile Site donor.


Finite cell line from late embryo of a donor with Ring Chromosome 13 Syndrome.


Finite cell line from a Ring chromosome 13 syndrome donor's late embryo.


Finite cell line from a Arteriohepatic Dysplasia donor's entire skin.


Transformed cell line derived from vertebrate blood of a Arteriohepatic Dysplasia donor.


Finite cell line derived from a Alagille Syndrome donor's liver.


Finite cell line from a Arteriohepatic Dysplasia patient's vertebrate dermis.


Finite cell line derived from entire skin of a donor with Alagille syndrome.


Transformed cell line from portion of blood of a donor with Alagille syndrome.


Alagille syndrome Finite cell line from liver.


Finite cell line derived from a Alagille syndrome donor's vertebrate dermis.


Transformed cell line from portion of blood of a Smith-Lemli-Opitz Syndrome donor.


Transformed cell line from portion of blood of a Smith-Lemli-Opitz syndrome donor.


Transformed cell line from a Manic Bipolar Affective Disorder donor's vertebrate blood.


Laurence-Moon Syndrome Transformed cell line from portion of blood.


Transformed cell line from portion of blood of a Bardet-Biedl syndrome donor.


Transformed cell line from vertebrate blood of a Major Depression patient.


Miller-Dieker Syndrome Finite cell line derived from entire skin.


Finite cell line from skin of arm of a Miller-Dieker Lissencephaly Syndrome patient.


Finite cell line from a Miller-Dieker Lissencephaly Syndrome donor's gonad of male reproductive system.


Finite cell line derived from a Miller-Dieker Syndrome donor's lung primordium.


Miller-Dieker Syndrome Finite cell line from future diaphragm.


Miller-Dieker Lissencephaly Syndrome Finite cell line from skeletal muscle tissue of diaphragm.


Miller-Dieker syndrome Finite cell line derived from entire skin.


Finite cell line from skin of arm of a Miller-Dieker syndrome patient.


Finite cell line derived from a Miller-Dieker syndrome donor's testicle.


Finite cell line derived from a Miller-Dieker syndrome patient's lung primordium.


Finite cell line from a Miller-Dieker syndrome donor's future diaphragm.


Miller-Dieker syndrome Finite cell line derived from skeletal muscle tissue of diaphragm.


Finite cell line from entire skin of a Pyruvate Carboxylase Deficiency Disease patient.


Finite cell line from a Pyruvate carboxylase deficiency patient's skin organ.


Transformed cell line derived from vertebrate blood of a donor with Osteopetrosis with Renal Tubular Acidosis.


Osteopetrosis with renal tubular acidosis Transformed cell line from portion of blood.


Ring Chromosome 21 Syndrome Finite cell line from late embryo.


Finite cell line derived from foreskin of penis of a donor with Ring Chromosome 21 Syndrome.


Finite cell line derived from late embryo of a Ring chromosome 21 syndrome patient.


Finite cell line from preputial skin of a Ring chromosome 21 syndrome patient.


Transformed cell line derived from portion of blood of a EPP patient.


Transformed cell line derived from a Autosomal erythropoietic protoporphyria donor's vertebrate blood.


idic Transformed cell line derived from portion of blood.


Finite cell line from skin organ of a Trichothiodystrophy 4, Nonphotosensitive donor.


Finite cell line from skin organ of a Trichothiodystrophy patient.


Transformed cell line derived from a Trichothiodystrophy patient's vertebrate blood.


Transformed cell line derived from a Aniridia donor's vertebrate blood.


Transformed cell line from portion of blood of a Isolated aniridia donor.


Cutaneous Malignant Melanoma 2 Transformed cell line from vertebrate blood.


Transformed cell line from a Familial melanoma patient's portion of blood.


Transformed cell line derived from portion of blood of a SCA1 patient.


Transformed cell line derived from portion of blood of a patient with Spinocerebellar ataxia type 1.


Transformed cell line derived from vertebrate blood of a patient with Combined Lipase Deficiency.


Transformed cell line from a Familial lipase maturation factor 1 deficiency patient's portion of blood.


Transformed cell line from a Nijmegen Breakage Syndrome patient's skin organ.


Finite cell line derived from skin organ of a donor with Nijmegen Breakage Syndrome.


Transformed cell line derived from a Nijmegen Breakage Syndrome patient's portion of blood.


Nijmegen breakage syndrome Transformed cell line derived from entire skin.


Finite cell line from a Nijmegen breakage syndrome donor's entire skin.


Transformed cell line derived from a Nijmegen breakage syndrome patient's vertebrate blood.


Transformed cell line from portion of blood of a donor with ACHM2.


Transformed cell line from a Achromatopsia patient's vertebrate blood.


Finite cell line from a Pelizaeus-Merzbacher Disease donor's entire skin.


Transformed cell line from portion of blood of a Pelizaeus-Merzbacher Disease patient.


Finite cell line derived from skin organ of a Pelizaeus-Merzbacher disease patient.


Transformed cell line derived from a Pelizaeus-Merzbacher disease donor's portion of blood.


Hypomanic Mood Transformed cell line from vertebrate blood.


Transformed cell line from portion of blood of a Holoprosencephaly donor.


Finite cell line derived from late embryo of a Holoprosencephaly donor.


Transformed cell line derived from a Holoprosencephaly patient's vertebrate blood.


Finite cell line derived from late embryo of a Holoprosencephaly patient.


Transformed cell line derived from portion of blood of a patient with Adenine Phosphoribosyltransferase Deficiency.


Transformed cell line derived from vertebrate blood of a Adenine phosphoribosyltransferase deficiency donor.


Transformed cell line from a Peroxisome Biogenesis Disorder 7A donor's portion of blood.


Peroxisome Biogenesis Disorder 7A Finite cell line derived from skin of arm.


Finite cell line from a Peroxisome biogenesis disorder patient's skin organ.


Transformed cell line from vertebrate blood of a patient with Peroxisome biogenesis disorder.


Peroxisome biogenesis disorder Finite cell line derived from skin of arm.


Trisomy 20 Finite cell line derived from chorionic villus.


Transformed cell line from a Wilms' Tumor patient's vertebrate blood.


MCAD Transformed cell line from portion of blood.


Transformed cell line derived from a Medium chain acyl-CoA dehydrogenase deficiency patient's portion of blood.


Chronic Granulomatous Disease Transformed cell line from vertebrate blood.


Chronic granulomatous disease Transformed cell line from portion of blood.


Transformed cell line derived from a Psychosis patient's vertebrate blood.


Finite cell line from late embryo of a Hypochondrogenesis donor.


Finite cell line derived from a Achondrogenesis type 2 patient's late embryo.


Transformed cell line derived from a TETRALOGY OF FALLOT donor's vertebrate blood.


Transformed cell line derived from a Tetralogy of Fallot donor's portion of blood.


CATCH-22 Finite cell line from skin organ.


Transformed cell line derived from a DiGeorge syndrome patient's portion of blood.


Finite cell line from skin organ of a 22q11.2 deletion syndrome patient.


Transformed cell line from a 22q11.2 deletion syndrome donor's vertebrate blood.


Rett Syndrome Finite cell line from entire skin.


Transformed cell line from portion of blood of a donor with Rett Syndrome.


Finite cell line derived from tonsil of a donor with Rett Syndrome.


Rett syndrome Finite cell line from entire skin.


Transformed cell line derived from vertebrate blood of a patient with Rett syndrome.


Rett syndrome Finite cell line from tonsil.


Transformed cell line from a Hereditary Spherocytosis patient's portion of blood.


Hereditary Spherocytosis Transformed cell line from spleen.


Hereditary spherocytosis Transformed cell line from portion of blood.


Transformed cell line from a Hereditary spherocytosis donor's spleen.


Finite cell line derived from amniotic fluid of a patient with Renal Hamartomas, Nephroblastomatosis and Fetal Gigantism.


Perlman syndrome Finite cell line derived from amniotic fluid.


Transformed cell line derived from portion of blood of a Liver Cirrhosis patient.


Undefined cell line type derived from a Unspecified cirrhosis of liver patient's liver.


Transformed cell line derived from a Beckwith-Wiedemann syndrome donor's portion of blood.


Finite cell line from a Beckwith-Wiedemann Syndrome donor's liver.


Beckwith-Wiedemann syndrome Transformed cell line derived from vertebrate blood.


Finite cell line from liver of a Beckwith-Wiedemann syndrome donor.


Hereditary Factor X Deficiency Transformed cell line from vertebrate blood.


Congenital factor X deficiency Transformed cell line from vertebrate blood.


Transformed cell line derived from a Factor IX Deficiency patient's portion of blood.


Transformed cell line from vertebrate blood of a patient with Hemophilia B.


Transformed cell line from a HSAN4 donor's portion of blood.


Hereditary sensory and autonomic neuropathy type 4 Transformed cell line derived from vertebrate blood.


Transformed cell line derived from vertebrate blood of a donor with Porphyria Cutanea Tarda.


Transformed cell line derived from portion of blood of a Porphyria cutanea tarda donor.


Transformed cell line from vertebrate blood of a Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 1 patient.


ICF syndrome Transformed cell line from portion of blood.


Transformed cell line from a Autosomal Dominant Polycystic Kidney Disease donor's portion of blood.


Autosomal dominant polycystic kidney disease Transformed cell line derived from portion of blood.


Finite cell line derived from a Zellweger Syndrome patient's entire skin.


Transformed cell line derived from vertebrate blood of a Zellweger Syndrome donor.


Finite cell line derived from a Zellweger syndrome patient's skin organ.


Transformed cell line derived from a Zellweger syndrome patient's portion of blood.


Transformed cell line from vertebrate blood of a Multiple Endocrine Neoplasia Type 2 donor.


Cancer cell line derived from a Multiple Endocrine Neoplasia Type 2 donor's thyroid.


Multiple Endocrine Neoplasia Type 2 Finite cell line from adrenal gland cortex.


Transformed cell line derived from a Multiple endocrine neoplasia type 2 donor's portion of blood.


Cancer cell line from thyroid of a Multiple endocrine neoplasia type 2 donor.


Multiple endocrine neoplasia type 2 Finite cell line derived from adrenal gland cortex.


Finite cell line derived from entire skin of a Osteogenesis Imperfecta Type II patient.


Finite cell line from late embryo of a Osteogenesis Imperfecta Type II donor.


Finite cell line derived from a Osteogenesis Imperfecta Type II donor's abdominal skin.


Finite cell line derived from a Osteogenesis imperfecta type 2 donor's skin organ.


Finite cell line from a Osteogenesis imperfecta type 2 patient's late embryo.


Osteogenesis imperfecta type 2 Finite cell line derived from abdomen skin.


Transformed cell line from a Batten Disease donor's portion of blood.


OBSOLETE: Congenital neuronal ceroid lipofuscinosis Finite cell line from entire skin.


OBSOLETE: Congenital neuronal ceroid lipofuscinosis Transformed cell line from vertebrate blood.


Multiple Sclerosis Transformed cell line from vertebrate blood.


Achondroplasia Finite cell line from entire skin.


Transformed cell line derived from vertebrate blood of a donor with Achondroplasia.


Achondroplasia Finite cell line derived from entire skin.


Transformed cell line from a Achondroplasia donor's portion of blood.


Mucopolysaccharidosis Type IIIC Transformed cell line derived from vertebrate blood.


Transformed cell line derived from vertebrate blood of a Sanfilippo syndrome type C patient.


Finite cell line from skin organ of a patient with Ornithine Carbamoyltransferase Deficiency Disease.


Transformed cell line from portion of blood of a Ornithine Carbamoyltransferase Deficiency Disease patient.


Finite cell line derived from liver of a patient with Ornithine Transcarbamylase Deficiency.


Ornithine transcarbamylase deficiency Finite cell line from entire skin.


Transformed cell line from a Ornithine transcarbamylase deficiency patient's portion of blood.


Finite cell line from liver of a donor with Ornithine transcarbamylase deficiency.


Transformed cell line from vertebrate blood of a Usher Syndrome Type 2 donor.


Transformed cell line from portion of blood of a donor with Usher syndrome type 2.


Finite cell line from entire skin of a patient with Gyrate Atrophy.


Finite cell line from skin organ of a Gyrate atrophy of choroid and retina patient.


Infantile Neuroaxonal Dystrophy Finite cell line from pulmo.


Finite cell line from a Infantile Neuroaxonal Dystrophy patient's entire skin.


Finite cell line from pulmo of a donor with Infantile neuroaxonal dystrophy.


Finite cell line derived from skin organ of a donor with Infantile neuroaxonal dystrophy.


Finite cell line from skin organ of a Crigler-Najjar Syndrome donor.


Crigler-Najjar Syndrome Transformed cell line derived from vertebrate blood.


Crigler-Najjar syndrome Finite cell line from entire skin.


Transformed cell line from a Crigler-Najjar syndrome donor's vertebrate blood.


Carboxypeptidase N Deficiency Transformed cell line from vertebrate blood.


Finite cell line derived from a Rhizomelic Chondrodysplasia Punctata patient's skin organ.


Transformed cell line derived from a Rhizomelic Dwarfism patient's vertebrate blood.


Finite cell line derived from entire skin of a Rhizomelic chondrodysplasia punctata patient.


Transformed cell line derived from a Rhizomelic chondrodysplasia punctata patient's portion of blood.


NF2 Transformed cell line from portion of blood.


neurofibromatosis type 2 Transformed cell line derived from vestibulocochlear VIII nerve vestibular component.


Transformed cell line derived from a Full NF2-related schwannomatosis donor's portion of blood.


Transformed cell line derived from a Full NF2-related schwannomatosis donor's vestibulocochlear VIII nerve vestibular component.


Finite cell line from a XP-D patient's entire skin.


XP-D Transformed cell line from skin organ.


XP-D Transformed cell line from vertebrate blood.


Finite cell line from skin of arm of a donor with XP-D.


Finite cell line derived from funiculus umbilicalis of a donor with Xeroderma Pigmentosum, Complementation Group D.


Finite cell line from pulmo of a Neonatal Hemochromatosis patient.


Neonatal Hemochromatosis Finite cell line from entire skin.


Finite cell line derived from a Neonatal hemochromatosis donor's pulmo.


Finite cell line from skin organ of a patient with Neonatal hemochromatosis.


Hereditary Factor II Deficiency Transformed cell line from portion of blood.


Congenital factor II deficiency Transformed cell line derived from vertebrate blood.


Transformed cell line from vertebrate blood of a donor with Junctional Epidermolysis Bullosa.


Junctional epidermolysis bullosa Transformed cell line from vertebrate blood.


Transformed cell line from portion of blood of a patient with Hereditary Factor VII Deficiency.


Transformed cell line derived from a Congenital factor VII deficiency donor's portion of blood.


Finite cell line from skin organ of a patient with Epidermolysis Bullosa Dystrophica.


Epidermolysis Bullosa Dystrophica Transformed cell line derived from portion of blood.


Finite cell line derived from a Dystrophic epidermolysis bullosa patient's skin organ.


Transformed cell line from a Dystrophic epidermolysis bullosa donor's vertebrate blood.


Transformed cell line from vertebrate blood of a CEP donor.


Transformed cell line from a Congenital erythropoietic porphyria patient's portion of blood.


Microcephalic Primordial Dwarfism Transformed cell line derived from vertebrate blood.


Seckel syndrome Transformed cell line derived from portion of blood.


Transformed cell line from a Hereditary hemorrhagic telangiectasia patient's vertebrate blood.


Transformed cell line derived from vertebrate blood of a Hereditary hemorrhagic telangiectasia patient.


Transformed cell line from portion of blood of a patient with Langer-Giedion Syndrome.


Transformed cell line from a Trichorhinophalangeal syndrome type 2 donor's vertebrate blood.


Transformed cell line from vertebrate blood of a Syndromic aniridia patient.


Cowden Syndrome Transformed cell line derived from portion of blood.


Finite cell line from a Ruvalcaba-Myhre-Smith Syndrome donor's thyroid.


Transformed cell line derived from a Cowden syndrome donor's vertebrate blood.


Finite cell line derived from a Cowden syndrome patient's thyroid.


Transformed cell line derived from a MDDGA1 donor's portion of blood.


Transformed cell line derived from a Walker-Warburg syndrome donor's portion of blood.


Orofacial Cleft 1 Transformed cell line from vertebrate blood.


Cleft lip/palate Transformed cell line derived from vertebrate blood.


Transformed cell line from portion of blood of a Cornelia De Lange Syndrome donor.


Transformed cell line derived from vertebrate blood of a Cornelia de Lange syndrome patient.


Finite cell line derived from entire skin of a donor with Jeune Syndrome.


Finite cell line derived from a Jeune syndrome patient's skin organ.


GKD Transformed cell line derived from portion of blood.


Transformed cell line derived from portion of blood of a Isolated glycerol kinase deficiency patient.


Finite cell line derived from entire skin of a patient with Polycystic Kidney Disease, Infantile Type.


Finite cell line from a Polycystic Kidney Disease, Infantile Type patient's kidney.